Akira Ooki

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Topics

Gas Chromatography

Metastatic Colorectal Cancer

Top Venues

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Journal of cancer research and clinical oncology

Therapeutic advances in medical oncology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Akira Ooki, Hiroki Osumi, Koichiro Yoshino, Kensei Yamaguchi
Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repair. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2024)
Akira Ooki, Hiroki Osumi, Koichiro Yoshino, Kensei Yamaguchi
Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repair. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (5) (2024)
Akira Ooki, Hiroki Osumi, Koichiro Yoshino, Kensei Yamaguchi
Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repair. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (5) (2024)
Koshiro Fukuda, Hiroki Osumi, Yuri Yoshinami, Akira Ooki, Atsuo Takashima, Takeru Wakatsuki, Hidekazu Hirano, Izuma Nakayama, Kota Ouchi, Ryoichi Sawada, Shota Fukuoka, Mariko Ogura, Daisuke Takahari, Keisho Chin, Hirokazu Shoji, Natsuko Okita, Ken Kato, Naoki Ishizuka, Narikazu Boku, Kensei Yamaguchi, Eiji Shinozaki
Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational study. Journal of cancer research and clinical oncology 150 (7) (2024)
Koshiro Fukuda, Hiroki Osumi, Yuri Yoshinami, Akira Ooki, Atsuo Takashima, Takeru Wakatsuki, Hidekazu Hirano, Izuma Nakayama, Kota Ouchi, Ryoichi Sawada, Shota Fukuoka, Mariko Ogura, Daisuke Takahari, Keisho Chin, Hirokazu Shoji, Natsuko Okita, Ken Kato, Naoki Ishizuka, Narikazu Boku, Kensei Yamaguchi, Eiji Shinozaki
Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational study. Journal of cancer research and clinical oncology 150 (7) (2024)
Koshiro Fukuda, Hiroki Osumi, Yuri Yoshinami, Akira Ooki, Atsuo Takashima, Takeru Wakatsuki, Hidekazu Hirano, Izuma Nakayama, Kota Ouchi, Ryoichi Sawada, Shota Fukuoka, Mariko Ogura, Daisuke Takahari, Keisho Chin, Hirokazu Shoji, Natsuko Okita, Ken Kato, Naoki Ishizuka, Narikazu Boku, Kensei Yamaguchi, Eiji Shinozaki
Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational study. Journal of cancer research and clinical oncology 150 (7) (2024)
Koshiro Fukuda, Hiroki Osumi, Yuri Yoshinami, Akira Ooki, Atsuo Takashima, Takeru Wakatsuki, Hidekazu Hirano, Izuma Nakayama, Kota Ouchi, Ryoichi Sawada, Shota Fukuoka, Mariko Ogura, Daisuke Takahari, Keisho Chin, Hirokazu Shoji, Natsuko Okita, Ken Kato, Naoki Ishizuka, Narikazu Boku, Kensei Yamaguchi, Eiji Shinozaki
Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational study. Journal of cancer research and clinical oncology 150 (7) (2024)
Akira Ooki, Hiroki Osumi, Koichiro Yoshino, Kensei Yamaguchi
Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repair. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (5) (2024)
Akira Ooki, Hiroki Osumi, Keisho Chin, Masayuki Watanabe, Kensei Yamaguchi
Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma. Therapeutic advances in medical oncology 15 (2023)
Koshiro Fukuda, Hiroki Osumi, Koichiro Yoshino, Izuma Nakayama, Shota Fukuoka, Mariko Ogura, Takeru Wakatsuki, Akira Ooki, Daisuke Takahari, Keisho Chin, Kensei Yamaguchi, Eiji Shinozaki
Single-organ pulmonary metastasis is a favorable prognostic factor in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors. BMC cancer 23 (1) (2023)
Akira Ooki, Hiroki Osumi, Koshiro Fukuda, Kensei Yamaguchi
Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma. Cancer metastasis reviews (2023)
Akira Ooki, Hiroki Osumi, Keisho Chin, Masayuki Watanabe, Kensei Yamaguchi
Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma. Therapeutic advances in medical oncology 15 (2023)
Akira Ooki, Kensei Yamaguchi
The dawn of precision medicine in diffuse-type gastric cancer. Therapeutic advances in medical oncology 14 (2022)
Akira Ooki, Kensei Yamaguchi
The beginning of the era of precision medicine for gastric cancer with fibroblast growth factor receptor 2 aberration. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 24 (6) (2021)
Masamichi Hayashi, Elisa Guida, Yoshikuni Inokawa, Rachel Goldberg, Leonardo Oliveira Reis, Akira Ooki, Manohar Pilli, Pritam Sadhukhan, Juhyung Woo, Woonyoung Choi, Evgeny Izumchenko, Leonel Maldonado Gonzalez, Luigi Marchionni, Alex Zhavoronkov, Mariana Brait, Trinity Bivalacqua, Alexander S Baras, George J Netto, Wayne Koch, Anju Singh, Mohammad Obaidul Hoque
GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma. Science signaling 13 (645) (2020)
Akira Ooki, Satoshi Morita, Shigeyoshi Iwamoto, Hiroki Hara, Hiroaki Tanioka, Hironaga Satake, Masato Kataoka, Masahito Kotaka, Yoshinori Kagawa, Masato Nakamura, Tatsushi Shingai, Masashi Ishikawa, Yasuhiro Miyake, Takeshi Suto, Yojiro Hashiguchi, Taichi Yabuno, Junichi Sakamoto, Akihito Tsuji, Masahiko Ando, Kensei Yamaguchi
Patient-reported symptom burden as a prognostic factor in treatment with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial. Cancer medicine 9 (5) (2020)
Akira Ooki, Satoshi Morita, Akihito Tsuji, Shigeyoshi Iwamoto, Hiroki Hara, Hiroaki Tanioka, Hironaga Satake, Masato Kataoka, Masahito Kotaka, Yoshinori Kagawa, Masato Nakamura, Tatsushi Shingai, Masashi Ishikawa, Yasuhiro Miyake, Takeshi Suto, Yojiro Hashiguchi, Taichi Yabuno, Masahiko Ando, Junichi Sakamoto, Kensei Yamaguchi
Disagreement between patient- and physician-reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial. Cancer medicine 9 (24) (2020)
Shigeyoshi Iwamoto, Akira Ooki, Satoshi Morita, Hiroki Hara, Hiroaki Tanioka, Hironaga Satake, Masato Kataoka, Masahito Kotaka, Yoshinori Kagawa, Masato Nakamura, Tatsushi Shingai, Masashi Ishikawa, Yasuhiro Miyake, Takeshi Sudo, Yojiro Hashiguchi, Taichi Yabuno, Junichi Sakamoto, Akihito Tsuji, Masahiko Ando, Kensei Yamaguchi
A prospective Phase II study to examine the relationship between quality of life and adverse events of first-line chemotherapy plus cetuximab in patients with KRAS wild-type unresectable metastatic colorectal cancer: QUACK trial. Cancer medicine 7 (9) (2018)
Akira Ooki, Wikum Dinalankara, Luigi Marchionni, Jun-Chieh J Tsay, Chandra Goparaju, Zahra Maleki, William N Rom, Harvey I Pass, Mohammad O Hoque
Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma. Oncogene 37 (45) (2018)
Akira Ooki, Kiwamu Akagi, Toshimasa Yatsuoka, Masako Asayama, Hiroki Hara, Yoji Nishimura, Hiroshi Katoh, Keishi Yamashita, Masahiko Watanabe, Kensei Yamaguchi
Lymph Node Ratio as a Risk Factor for Recurrence After Adjuvant Chemotherapy in Stage III Colorectal Cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 21 (5) (2017)